CT colonography can pinpoint cancerous colorectal segments more accurately than colonoscopy, according to Italian investigators. They say virtual, not optical, colonoscopy should be the gold standard for the preoperative staging of colorectal cancer.
CT colonography can pinpoint cancerous colorectal segments more accurately than colonoscopy, according to Italian investigators. They say virtual, not optical, colonoscopy should be the gold standard for the preoperative staging of colorectal cancer.
The prognosis for patients diagnosed with colorectal cancer depends largely on the correct localization of diseased segments prior to tumor resection. Colonoscopy, the standard of care for this indication, could be plagued by multiple anatomical or physiological hurdles that hinder precise segment tracking in about three of every 10 patients. But CTC can overcome most of these limitations, said principal investigator Dr. Emanuele Neri, an assistant professor of diagnostic and interventional radiology at the University of Pisa.
"Gastroenterologists and surgeons should be aware of this and before surgery should always ask for a staging CT colonography," Neri told Diagnostic Imaging.
Neri and colleagues enrolled 65 patients diagnosed with colorectal cancer who underwent segmental localization of their tumors with colonoscopy and CTC before surgery. Of this group, 45 patients (69%) had to be referred to CTC after incomplete colonoscopy results due to discomfort or because of bowel narrowing from cancer.
CTC allowed a complete evaluation in all but two cases, where an obstructing lesion of the sigmoid prevented proper cleansing and insufflation. CTC accurately identified all diseased segments while colonoscopy missed 16 of them (24%). CTC's sensitivity, specificity, and positive and negative predictive values for precise location of colonic masses were, respectively, 100%, 96%, 85%, and 100%. Results appeared online in the Sept. 18 issue of Abdominal Imaging.
The accumulation of data keeps fueling the discussion regarding the value of CTC vis-à-vis colonoscopy. What is beyond any doubt is that CTC should at least replace double contrast barium enema, which has become an obsolete diagnostic tool, Neri said. Patients nowadays prefer CTC over barium enemas and the reasons go beyond comfort. For one, studies have shown a consistent reduction in radiation dose, averaging 2 to 3 mSv. Cost-effectiveness comes to the fore as well. In addition to a contrast-enhanced CTC, many surgeons still ask for a DCBE for preoperative staging and to get information on the precise location of cancer. This is absolute overkill, Neri said.
"CT colonography alone could get them better preoperative and staging information than two exams," he said.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.